S

Sentien Biotechnologies, Inc.

12 employees

Sentien is a developer of new blood conditioning therapies designed to restore balance to the immune system of critically ill patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2008

Funding rounds raised

Total raised

$12M

from 2 investors over 2 rounds

S

Sentien Biotechnologies, Inc. raised $12M on April 4, 2017

Investors: Chiesi Ventures and Mass Medical Angels

FAQ